Despite the highly significant diferences in the frequency distribution of AS ́s and CYP2C9 phenotypes across the study groups, the Cramer ́s V test pointed to small effect sizes in the cohorts and Brazilian subcohorts ( Supplementary Table S3 ).
← all excerpts
Pharmacogenomic implications of the differential distribution of CYP2C9 metabolic phenotypes among Latin American populations.
1
—
—